Patent · US Active

Substituted alkoxypyridinyl indolsulfonamides

US11976056B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

UCB Pharma GMBH · DE

Inventors

Cecile Pegurier · Uccle - Ukkel, BE
Laurent Provins · Soignies, BE
Emre M. Isin · Brussels, BE
Marie Ledecq · Éghezée, BE

Key dates

Filing date	Jun 19, 2019
Grant date	May 7, 2024
Priority date	—
Expiry date	Apr 16, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present application relates to alkoxy-substituted pyridinyl indolsulfonamides. The compounds are negative GPR17 modulators and have utility in the treatment of various GPR17 associated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.